Trademark: 85636625
Word
STOTIXA (TIVOZANIB HCL) CAPSULES
Status Date
Monday, February 24, 2014
Filing Date
Monday, May 28, 2012
Published for Opposition
Tuesday, November 27, 2012
Abandoned Date
Monday, February 24, 2014
5 Pharmaceutical preparations for the treatment of cancer, namely pharmaceutical preparations containing tivozanib hydrochloride
The color(s) blue, orange and yellow is/are claimed as a feature of the mark.
"TIVOZANIB HCL CAPSULES"
The mark consists of the wording "STOTIXA (TIVOZANIB HCL) CAPSULES" shown in blue, and the design of three overlapping curved vertical bands having pointed ends, with one band shown in shades of blue and orange, and the other two bands shown in shades in blue, orange and yellow.
Feb 24, 2014
Abandonment Notice Mailed - No Use Statement Filed
Feb 24, 2014
Abandonment - No Use Statement Filed
Jul 18, 2013
Notice Of Approval Of Extension Request E-Mailed
Jul 16, 2013
Extension 1 Granted
Jul 16, 2013
Extension 1 Filed
Jul 16, 2013
Teas Extension Received
Jan 22, 2013
Noa E-Mailed - Sou Required From Applicant
Nov 27, 2012
Official Gazette Publication Confirmation E-Mailed
Nov 27, 2012
Published For Opposition
Nov 7, 2012
Notification Of Notice Of Publication E-Mailed
Oct 22, 2012
Law Office Publication Review Completed
Oct 18, 2012
Assigned To Lie
Oct 3, 2012
Approved For Pub - Principal Register
Oct 3, 2012
Examiner's Amendment Entered
Oct 3, 2012
Notification Of Examiners Amendment E-Mailed
Oct 3, 2012
Examiners Amendment E-Mailed
Oct 3, 2012
Examiners Amendment -Written
Oct 3, 2012
Previous Allowance Count Withdrawn
Sep 14, 2012
Withdrawn From Pub - Og Review Query
Aug 31, 2012
Approved For Pub - Principal Register
Aug 30, 2012
Assigned To Examiner
Jun 6, 2012
Notice Of Design Search Code Mailed
Jun 5, 2012
New Application Office Supplied Data Entered In Tram
May 31, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
